Description

The product pictured is a sterile vial of Bew-lox, containing Botulinum Toxin Type A at a concentration of 150 Units. This specialized pharmaceutical is a highly purified, lyophilized (freeze-dried) neuromodulator, strictly intended for professional use in medical and cosmetic settings.

Key Visual Characteristics

The clear glass vial is hermetically sealed with a rubber stopper and a blue metallic crimp cap, ensuring maximum sterility and product integrity. The label clearly displays the commercial name, “Bew-lox,” and specifies the active ingredient, “Botulinum Toxin Type A,” along with the dosage of “150 UNITS.” The inner contents appear as a white, freeze-dried powder, which must be reconstituted with sterile saline solution prior to injection. The design includes a distinctive purple chevron pattern below the text.

Mechanism of Action and Indications

Botulinum Toxin Type A works by temporarily blocking the release of acetylcholine at the neuromuscular junction. This action results in localized and reversible muscle paralysis.

In the cosmetic field, Bew-lox 150 Units is commonly used to treat dynamic facial wrinkles caused by muscle contraction, such as glabellar lines (frown lines), crow’s feet, and forehead lines. The effect is a smoother, more youthful skin appearance.

In the therapeutic field, it may be used to manage conditions like cervical dystonia, blepharospasm, hyperhidrosis (excessive sweating), and chronic muscle spasticity.

Quality and Standardization

This formulation is designed to offer a high safety and efficacy profile, with purity intended to minimize the risk of immunological reactions. The 150 Units provide a standard quantity, allowing medical practitioners to customize the treatment based on the specific needs of the patient and the area being treated.